The Treasury Refunding Hits a Bond Market Already Moving
Auction sizes and long-end buybacks are on the table this morning, and the 10-year yield already gave back ground overnight.
Novo Nordisk Just Proved the Price War Story Was Wrong
A beat on every line and a third guidance raise in 2026 show the Wegovy pill is filling the gap faster than investors feared.
Vulcan’s Real Bet Is on Money Not Spent Yet
With roughly half of IIJA outlays still pending, Vulcan is pricing 2027 on backlog
DRAM Has Doubled. Is Micron the Buy, or the Warning Sign?
Memory is now rationed by contract, Korean producers plan steep PC output cuts, and Micron’s financials look extraordinary. That combination demands a hard question about timing.
German Gas at 61% Sends TTF Toward €100
Germany missed its Nov. 1 storage target. Here is where weather risk concentrates, which sectors are absorbing the damage, and why Cheniere may be the cleanest trade in the room.
Marriott’s Fee Model Is the Real Test in a Regional Collapse
A 43% Middle East RevPAR drop shows what an asset-light model is built for.
Tesla Shareholders Hold the Only Real Veto on a SpaceX Merger
Not voting counts as a no. Here is what you would give up, and gain.
Lula’s Party Is Blocking the Spending Fix the Real Needs
The finance minister pick could reverse or deepen a week of market damage.
China’s Factory PMI Missed 50.0. Miners Face Monday.
A 49.3 reading below every major forecast puts BHP, RIO, and commodity-linked names in the crosshairs at the open.
The Nasdaq 100 Is in Correction. AI Is Being Priced as Debt.
Friday’s $1 trillion wipeout was not just a bad day for tech stocks. It was the market demanding proof that borrowed money can buy a return.